For the primary outcomes chosen in our review, no data were identified from the five trials. With regard to potential adverse events, there was only one trial reporting on this outcome. Only the type of adverse events were reported in that trial and no patients required dose modification, interruption or prolonged hospitalisation. However, insufficient evidence for adverse events of phyllanthus from randomised trials cannot lead to the conclusion that phyllanthus does not cause harm.